Related Experiment Video
Updated: Dec 8, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Antidepressant treatment in patients following acute coronary syndromes: a systematic review and Bayesian
Romy Sweda1,2, George C M Siontis1, Adriani Nikolakopoulou3
1Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, CH-3010, Switzerland.
Insights
Antidepressant therapy after acute coronary syndrome (ACS) does not impact mortality but reduces hospitalizations. For ACS patients with depression, antidepressants lower the risk of recurrent myocardial infarction.
Area of Science:
- Cardiology
- Psychiatry
- Pharmacology
Background:
- Acute coronary syndrome (ACS) is a critical cardiovascular event.
- Depression is a common comorbidity in ACS patients, impacting outcomes.
- The role of antidepressant therapy in managing ACS patients is under investigation.
Purpose of the Study:
- To evaluate the impact of antidepressant therapy on mortality and cardiovascular outcomes in patients post-ACS.
- To assess the efficacy of antidepressants in reducing all-cause mortality, repeat hospitalizations, and recurrent myocardial infarctions (MIs).
Main Methods:
- A systematic search of PubMed, Embase, and Cochrane Central Register was conducted.
- Bayesian random-effects meta-analysis of 10 randomized controlled trials (1935 patients) was performed.
- Primary outcome: all-cause mortality. Secondary outcomes: repeat hospitalizations and recurrent MIs.
Main Results:
- Antidepressant therapy showed no significant effect on all-cause mortality (OR 0.97, 95% CrI 0.66-1.42) or recurrent MI (OR 0.64, 95% CrI 0.40-1.02).
- A significant reduction in repeat hospitalizations was observed with antidepressant use (OR 0.62, 95% CrI 0.40-0.94).
- In ACS patients with depression, antidepressants significantly reduced the odds of recurrent MI (OR 0.45, 95% CrI 0.25-0.81).
Conclusions:
- Antidepressants do not influence mortality rates in patients following ACS.
- Antidepressant therapy is associated with a decrease in repeat hospitalizations post-ACS.
- For ACS patients experiencing depression, antidepressant treatment offers a reduced risk of recurrent myocardial infarction.
Aims:
The aim of this study is to investigate the effect of antidepressant therapy on mortality and cardiovascular outcomes in patients with acute coronary syndrome (ACS).
Methods And Results:
We systematically searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials and performed a Bayesian random-effects meta-analysis of randomized controlled trials that investigated antidepressant pharmacotherapy in patients following ACS. The primary outcome was all-cause mortality. Secondary outcomes were repeat hospitalizations and recurrent myocardial infarctions (MIs). Ten randomized controlled trials with a total of 1935 patients qualified for inclusion. Selective serotonin reuptake inhibitors were investigated in six, bupropion in three, and mirtazapine in one trial. Placebo was used as control in eight trials. There was no difference in all-cause mortality [odds ratio (OR) 0.97, 95% credible interval (CrI) 0.66-1.42] and recurrent MI (OR 0.64, 95% CrI 0.40-1.02) between patients receiving antidepressants compared with controls, whereas antidepressant therapy was associated with less repeat hospitalizations (OR 0.62, 95% CrI 0.40-0.94). In patients with ACS and concomitant depression, antidepressants reduced the odds of recurrent MI compared with usual care/placebo (OR 0.45, 95% CrI 0.25-0.81). Extended funnel plots suggest robustness of the observations.
Conclusions:
Antidepressants in patients following ACS have no effect on mortality but reduce repeat hospitalizations; in patients with depression, there is a reduced risk of recurrent MI with antidepressant therapy.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Acute Coronary Syndrome III: Diagnostic Studies
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Acute Coronary Syndrome V: Nursing Management

